Biology

Prof. Emerita Nancy Hopkins speaks with ABC News about her work advocating for gender equality in academia and "The Exceptions: Nancy Hopkins, MIT, and the Fight for Women in Science,” a new book by Kate Zernike, a journalist who originally covered Hopkins’ efforts for The Boston Globe. Hopkins notes that when Zernike’s article was published, “this deluge happened. I mean, it was just overwhelming. And women were writing from all over the country and the world and saying, thank you. Thank you for telling the story. It's my story.”

Boston Globe reporter Ryan Cross spotlights Chroma Medicine, a biotech startup co-founded by MIT researchers that is “developing a new class of gene editing technologies that could control how our genetic code is read without changing the code itself.” Cross explains that Chroma Medicine’s technology could “have broad applications for treating both rare and common diseases.”

Bloomberg reporter Tanaz Meghjani writes that MIT researchers created a new system to 3D print a customized replica of the human heart, which could help improve replacement valve procedures. The new system “mimics blood flow and pressure in individual diseased hearts, suggesting a way to predict the effects of various replacements and select the best fit, avoiding potential leakage and failure,” Meghjani writes.

MIT engineers have developed a new technique for 3D printing a soft, flexible, custom-designed replica of a patient’s heart, report Gabrielle Emanuel and Amy Sokolow for WBUR. The goal of the research is to “provide realistic models so that doctors, researchers and medical device manufacturers can use them in testing therapies for different types of heart disease,” Emanuel and Sokolow explain.

Prof. Philip Sharp speaks with Biomarker blogger Dylan Neel about his journey through academia as a student, professor, Nobel laureate and biotech pioneer. “Science has become such an important part of our day-to-day lives: our immediate health, the food we eat, the cars we drive, the way we communicate,” says Sharp. “If you take a portion of the tools we use in our day-to-day lives and trace them all back: it's new technology, maybe not over 30 years old. It is very empowering. Life and progress are better than ever before.” 

President Sally Kornbluth, Provost Cynthia Barnhart, and Chancellor Melissa Nobles speak with Radio Boston host Tiziana Dearing about the importance of representation for women and underrepresented groups in STEM. “One of the most important pieces of having women in leadership is not just bringing a diverse perspective, but honestly being role models so that girls see that there is a possibility for them to be doing the kind of high-tech, heavy research that MIT does,” says Kornbluth. 

Researchers from MIT and Harvard have developed “a new type of electrically conductive hydrogel ‘scaffold’ that could eventually be used to create a soft brain-computer interface (or BCI) that translates neural signals from the brain into machine-readable instructions,” reports Adam Bluestein for Fast Company.

Natalia Rodriguez ’09 speaks with Diverse Issues in Higher Education reporter Pearl Stewart about her work as a biomedical engineer focused on community healthcare. “I work to bring health technologies from the lab to the people, and I also work to bring the needs, the priorities and the strengths of communities back to engineers so they know who they’re designing for,” Rodriguez explains. 

Sally Kornbluth, the 18^th president of MIT, speaks with Boston Magazine reporter Jonathan Soroff about why she is excited to lead MIT, Smoots, Boston weather and sports, and how to encourage more girls and women to pursue STEM careers.

New York Times reporter Siobhan Roberts spotlights the work of Jessica Rosenkrantz ’05 and her husband Jesse Louis-Rosenberg, who create laser-cut, wooden jigsaw puzzles inspired by natural forms. “Inspired by how shapes and forms emerge in nature, they write custom software to ‘grow’ intertwining puzzle pieces,” writes Roberts. “Their signature puzzle cuts have names like dendrite, amoeba, maze and wave.”

Research from Synlogic, a biotech company founded by Profs James Collins and Timothy Lu, has found that it’s the company’s engineered bacteria could provide some benefit to patients with a rare genetic disease, reports Emily Mullin for Wired. “Similar to how you might program a computer, we can tinker with the DNA of bacteria and have them do things like produce a drug at the right time and the right place, or in this case, break down a toxic metabolite,” says Lu.

Prof. Matthew Wilson speaks with National Geographic reporter Brian Handwerk about his research exploring the science behind whether animals have dreams. “We have this idea of dreams being a confabulatory narrative with kind of crazy, vivid elements to it,” says Wilson. “But when we look into animal models, we’re simply trying to understand what goes on during sleep that might influence learning, memory, and behavior.”

Duke Provost Sally Kornbluth has been named the next president of MIT, reports Paul Basken for Times Higher Education. “MIT’s announcement credited Professor Kornbluth with prioritizing investments in faculty, especially from under-represented groups, and strengthening interdisciplinary research and education,” writes Basken.

Forbes contributor Michael T. Nietzel spotlights how Sally Kornbluth, the provost of Duke University, has been selected as the 18^th President-elect of MIT. “A highly accomplished researcher, Kornbluth is currently the Jo Rae Wright University Professor of Biology at Duke where she has been a member of the faculty since 1994, first in the Department of Pharmacology and Cancer Biology at the Duke University School of Medicine and then as a member of the Department of Biology in the Trinity College of Arts and Sciences,” writes Nietzel.

President-elect Sally Kornbluth discusses her hopes and aspirations for her tenure as MIT’s president with Katie Mogg of The Boston Globe. “I just want to continue the excellence of MIT,” she said. “I hope when I turn my head back down the road some years from now that this will have been viewed as a period of continued excellence, but also of the discovery, innovation, and invention of things that continue to really have a huge impact on the world stage.”